<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04571905</url>
  </required_header>
  <id_info>
    <org_study_id>CTU 18.028</org_study_id>
    <nct_id>NCT04571905</nct_id>
  </id_info>
  <brief_title>MagnezixKids Study</brief_title>
  <official_title>&quot;Magnesium-based, Bioresorbable Implants for Pediatric Elbow Fractures, a Single Center Pilot Study for Osteosynthesis With Magnezix Screws in Fractures of the Epicondylus Ulnaris and Condylus Radialis.&quot;</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Thomas Krebs</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ostschweizer Kinderspital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The overall objective of the study is to describe the outcomes of osteosyn-thesis with&#xD;
      magnesium based screws in children with a primary or second-ary (within 7 days from trauma)&#xD;
      dislocated fracture of the Epicondyles ul-naris or Condylus radialis, and to compare them&#xD;
      with outcomes of conven-tional osteosynthesis using steel screws.&#xD;
&#xD;
      If our results suggest non-inferiority of osteosynthesis with magnesium-based screws, the&#xD;
      procedure could be tested formally in a subsequent full-size study.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2020</start_date>
  <completion_date type="Anticipated">February 28, 2023</completion_date>
  <primary_completion_date type="Anticipated">February 28, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical and radiologic outcome (fracture consolidation)</measure>
    <time_frame>12 months</time_frame>
    <description>radiologic outcome after osteosynthesis with magnesium based screws in children with a primary or secondary (within 7 days from trauma) dislocated fracture of the Epicondyles ulnaris or Condylus radialis Fracture alignment is measured as dislocation distance (mm). Appropriate alignement is a postopera-tive dehiscence or dislocation of less than 5 mm in Epicondylus ulnaris fractures and less than 2 mm in Condylus radialis fractures, according to literature (26/27/31).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Analgesic reuirement</measure>
    <time_frame>12 months</time_frame>
    <description>Analgesic requirement via Pain score (Visual Analog Scale, VAS, Range from 1 (no pain) to 10 (strongest pain)) (27) at every study visit (except visit 1: preop. assessment)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ROM</measure>
    <time_frame>12 months</time_frame>
    <description>Clinical reassessment at Routine follow-ups at every study visit&#xD;
- An Arc &gt;100° shows a good functional result, arc 50-100° is a fair (acceptable) result, arc &lt;50° shows a poor (unsatisfactory) result, according to the Mayo elbow performance index (see appendix).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Woundhealing</measure>
    <time_frame>12 months</time_frame>
    <description>Clinical reassessment at Routine follow-ups at every study visit&#xD;
- Classification in normal or delayed/impaired. Signs for im-pairment are local secretion, swelling, reddening or wound dehiscence.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical fracture consolidation after one year</measure>
    <time_frame>12 months</time_frame>
    <description>Clinical reassessment at Routine follow-ups at every study visit&#xD;
- Clinical signs for good consolidation are: no pain while palpating the fracture site.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Magnesium-based</condition>
  <condition>Bioresrobable Implants</condition>
  <condition>Pediatric Elbow Fractures</condition>
  <condition>Osteosynthesis</condition>
  <condition>Childhood</condition>
  <condition>Magnezix</condition>
  <condition>Elbow Fracture</condition>
  <arm_group>
    <arm_group_label>Syntellix Treatment Arm</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>General anaesthesia, open fracture reduction, insertion of the appropriate screw with x-ray control and documentation intraoperatively, cast immobilisation Use of bioresorbable Magnezix CS or CBS Screws, if intraoperatively suitable bioresorbable screws not available, use of conventional ostesynthesis screws</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Osteosynthesis with resorbable Material</intervention_name>
    <description>Osteosynthesis with Magnezix screws in fractures of the Epicondylus ulnaris and Condylus radialis under General anaesthesia</description>
    <arm_group_label>Syntellix Treatment Arm</arm_group_label>
    <other_name>Magnezix (Syntellix) screws</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  primary or secondary (within 7 days from trauma) dislocated fracture of the&#xD;
             Epicondyles ulnaris or Condylus radialis (indication for operative treatment according&#xD;
             to international standard: Dislocation of more than 2 mm in Condylus radials fractures&#xD;
             and more than 5 mm in Epicondylus ulnas fractures )&#xD;
&#xD;
          -  Age 3-15 years&#xD;
&#xD;
          -  Informed Consent as documented by signature&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  - open fractures or complex multi fragment fractures that require dif-ferent&#xD;
             osteosynthetic procedures than screw fixation&#xD;
&#xD;
          -  severe local accompanying injury (injury to nerves/vessels)&#xD;
&#xD;
          -  polytrauma patients&#xD;
&#xD;
          -  fracture age &gt; 7 days&#xD;
&#xD;
          -  preexisting ipsilateral elbow fracture&#xD;
&#xD;
          -  relevant comorbidities, which have influence on fracture and wound healing&#xD;
&#xD;
          -  Inability to follow the procedures of the study, e.g. due to language problems,&#xD;
             psychological disorders, dementia, etc. of the participant or the legal&#xD;
             representatives&#xD;
&#xD;
          -  Previous enrolment into the current study&#xD;
&#xD;
          -  Enrolment of the investigator's family members and other dependent persons&#xD;
&#xD;
          -  Any of the following applicable absolute and relative contraindica-tions listed in the&#xD;
             MAGNEZIX® CBS and CSc 4.8 mm instruction for use :&#xD;
&#xD;
        Absolute contraindications:&#xD;
&#xD;
          -  insufficient or avascular bone mass for anchorage of the implant, ex-cept&#xD;
             osteochondral fractures and dissecates&#xD;
&#xD;
          -  confirmation or suspected septic infectious surgical site&#xD;
&#xD;
          -  application in the area of the epiphyseal plates&#xD;
&#xD;
        Relative contraindications:&#xD;
&#xD;
          -  acute sepsis&#xD;
&#xD;
          -  alcohol, nicotine and/or drug abuse&#xD;
&#xD;
          -  epilepsy&#xD;
&#xD;
          -  poor skin/soft tissue conditions&#xD;
&#xD;
          -  uncooperative patient or patient with restricted intellectual capacity&#xD;
&#xD;
          -  no options for adequate postoperative treatment (e.g. temporary strain relief)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>15 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Christoph Matissek, MD</last_name>
    <phone>+41 243 14 53</phone>
    <email>christoph.matissek@kispisg.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Thomas F Krebs, MD</last_name>
    <phone>+41 243 19 05</phone>
    <email>thomas.krebs@kispisg.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Childres Hospital of Eastern Switzerland</name>
      <address>
        <city>Saint Gallen</city>
        <zip>9006</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christoph Matissek, MD</last_name>
      <phone>+41 243 14 53</phone>
      <email>christoph.matissek@kispisg.ch</email>
    </contact>
    <contact_backup>
      <last_name>Thomas F Krebs, MD</last_name>
      <phone>+41 243 19 05</phone>
      <email>thomas.krebs@kispisg.ch</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>August 11, 2020</study_first_submitted>
  <study_first_submitted_qc>September 25, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 1, 2020</study_first_posted>
  <last_update_submitted>September 25, 2020</last_update_submitted>
  <last_update_submitted_qc>September 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 1, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Ostschweizer Kinderspital</investigator_affiliation>
    <investigator_full_name>Thomas Krebs</investigator_full_name>
    <investigator_title>Surgeon in Chief, Member of the executive board</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fractures, Bone</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

